Brief: Transcode Therapeutics Reports Successful Treatment Of Preclinical Melanoma Tumors With Its Immunotherapy Candidate, TTX-RIGA

Transcode Therapeutics

16/10/2023 14:04

Oct 16 (Reuters) - Transcode Therapeutics Inc  RNAZ.O :
    * TRANSCODE THERAPEUTICS REPORTS SUCCESSFUL TREATMENT OF
PRECLINICAL MELANOMA TUMORS WITH ITS IMMUNOTHERAPY CANDIDATE,
TTX-RIGA
    * TRANSCODE THERAPEUTICS INC - ADMINISTRATION DIRECTLY INTO
TUMOR
HAS NOT PROVEN CLINICALLY EFFECTIVE DUE TO LIMITED ACCESS TO
TUMOR CELLS

Source text for Eikon:  ID:nGNX2rwTc5 
Further company coverage:  RNAZ.O 

 ((Reuters.Briefs@thomsonreuters.com;))